Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000350055 | SCV000344488 | likely benign | not specified | 2016-08-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697710 | SCV000531543 | benign | not provided | 2020-07-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000877929 | SCV001020748 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Al Jalila Children's Genomics Center, |
RCV000350055 | SCV001984207 | likely benign | not specified | 2020-09-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418134 | SCV002721662 | likely benign | Cardiovascular phenotype | 2019-07-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001697710 | SCV002821851 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BS1 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000350055 | SCV003929241 | likely benign | not specified | 2023-04-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977811 | SCV004794911 | likely benign | FLNC-related disorder | 2020-04-16 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001697710 | SCV001930212 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001697710 | SCV001975802 | likely benign | not provided | no assertion criteria provided | clinical testing |